483 American Red Cross National Headquarters Apr 2000

483 American Red Cross National Headquarters Apr 2000

Mary Carden FDA, Linda Mattingly FDA$119.00 - Available Now

FDA investigators audited the American Red Cross National Headquarters - Washington, DC, United States facility and issued inspectional observations (via FDA 483) on 26 Apr 2000.

Product details

  • Category: Biologics
  • Inspection end: 26 Apr 2000
  • Location: Washington, United States
  • FEI: 1000123507
Add To Cart